MIRA Pharmaceuticals Reports Successful Formulation Results Supporting Development of MIRA-55 as a Non-Opioid Oral Therapy for Chronic Inflammatory Pain
Go back to MIRA Pharmaceuticals Reports Successful Formulation Results Supporting Development of MIRA-55 as a Non-Opioid Oral Therapy for Chronic Inflammatory Pain| Miracle Applications Corp (NASDAQ: MIRA) | Delayed: 0.88 +0.05 (6.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.83 | 52 Week High | $0.04 | |||
| Open | $0.82 | 52 Week Low | $0.00 | |||
| Day High | $0.90 | P/E | N/A | |||
| Day Low | $0.80 | EPS | $0.00 | |||
| Volume | 387,628 | |||||
